Digital Heart Monitoring Leverage Coala's FDA and CE-cleared digital heart monitoring ecosystem to target healthcare organizations seeking remote cardiac assessment capabilities, positioning the Coala solution as a modern replacement for analogue stethoscopes and enabling scalable remote patient monitoring.

Remote Patient Growth Capitalize on Coala Life's RPM presence in the US since 2022 and ongoing cloud-based monitoring to pursue health systems and payers expanding remote chronic disease management programs, emphasizing early detection and continuous cardiac data analytics.

Global Expansion Readiness Target international hospitals and clinics expanding digital health portfolios, using Coala's Swedish origin, patented technology, and multi-market readiness (CE/FDA cleared) to propose cross-border deployments and integration with existing EHR/telehealth workflows.

Strategic Partnerships Focus on advisory and capital-market relationships evidenced by a recent partnership with Carnegie Investment Bank, and position Coala as a strategic digital diagnostics partner for health networks seeking scalable cardiac screening and data-driven patient management.

Clinical Outcomes Focus Highlight the clinically oriented value proposition—simultaneous heart sounds, ECG, and heart rate analytics powered by smart algorithms—to address opportunities with cardiology groups, primary care networks, and long-term care facilities aiming for early intervention and improved outcomes.